rank	phenotype	cui	assoc in neigh	assoc in intom	probability	Benjamini-Hochberg	genes	
77	Human papilloma virus infection	C0343641	5	57	1.875880562e-10	3.1713344316309716e-05	STK11,CDKN2A,TP53,PML,MDM2
78	Adenoid Cystic Carcinoma	C0010606	7	200	2.26051288799e-10	3.2125205930807246e-05	PIN1,CDKN2A,TP53,EP300,KAT6A,MDM2,ATM
79	Leukemogenesis	C0598766	10	660	3.73447273105e-10	3.2537067545304775e-05	PIN1,HIPK2,CDKN2A,TP53,EP300,KAT6A,PRMT5,PML,MDM2,ATM
80	Testicular seminoma	C0036631	7	222	3.88982845934e-10	3.2948929159802305e-05	CDKN2A,TP53,PRMT5,PML,UBC,RPS27A,MDM2
81	Lymphoma, Large B-Cell, Diffuse	C0024299	13	1362	4.8674464459e-10	3.3360790774299834e-05	PIN1,ING2,NUAK1,CDKN2A,TP53,EP300,TP53BP2,PRMT5,PML,UBC,RPS27A,MDM2,ATM
83	Acute myeloid leukemia	C0023467	14	1733	9.17118270216e-10	3.418451400329489e-05	PIN1,HIPK2,BRD7,USP42,STK11,ING5,CDKN2A,TP53,EP300,TTC5,KAT6A,PML,MDM2,ATM
84	Stomach cancer	C0699791	15	2109	1.3027272594e-09	3.459637561779242e-05	PIN1,ING2,TP53INP1,STK11,ING5,CDKN2A,TP53,EP300,TP53BP2,PPP1R13B,PRMT5,PML,MDM2,DYRK2,ATM
88	Breast carcinoma	C0678222	20	4281	2.14304729518e-09	3.6243822075782534e-05	PIN1,HIPK2,ING2,BRD7,TP53INP1,STK11,NUAK1,CDKN2A,TP53,EP300,TP53BP2,PPP1R13B,KAT6A,PRMT5,PML,UBC,RPS27A,MDM2,DYRK2,ATM
89	Follicular adenoma	C0205647	5	94	2.16576845347e-09	3.665568369028006e-05	PIN1,HIPK2,CDKN2A,TP53,ATM
93	Leukemia, Lymphocytic, Chronic, B-Cell	C0023418	14	1913	3.45624950882e-09	3.830313014827018e-05	PIN1,HIPK2,TP53INP1,USP42,CDKN2A,TP53,EP300,TP53BP2,TTC5,KAT6A,PRMT5,PML,MDM2,ATM
94	Li-Fraumeni syndrome	C0085390	4	47	3.92060872656e-09	3.871499176276771e-05	CDKN2A,TP53,MDM2,ATM
95	Isochromosomes	C0242621	4	47	3.92060872656e-09	3.912685337726524e-05	CDKN2A,TP53,PML,ATM
96	Nijmegen Breakage Syndrome	C0398791	4	47	3.92060872656e-09	3.953871499176276e-05	CDKN2A,TP53,MDM2,ATM
97	Papillomavirus Infections	C0950124	4	49	4.80299677807e-09	3.995057660626029e-05	CDKN2A,TP53,PML,MDM2
98	Acute respiratory failure	C0264490	4	51	5.89966031583e-09	4.036243822075782e-05	CDKN2A,TP53,MDM2,ATM
99	Breast-ovarian cancer, familial 1	C0006142	20	4543	6.42125497219e-09	4.077429983525535e-05	PIN1,HIPK2,ING2,BRD7,TP53INP1,STK11,NUAK1,CDKN2A,TP53,EP300,PPP1R13B,KAT6A,PRMT5,PML,UBC,RPS27A,JMY,MDM2,DYRK2,ATM
100	Leukoplakia	C0023531	4	52	6.48723696983e-09	4.118616144975288e-05	CDKN2A,TP53,MDM2,ATM
108	Brain Tumor, Primary	C0750974	4	54	7.87095655319e-09	4.448105436573312e-05	CDKN2A,TP53,MDM2,ATM
109	Hereditary nonpolyposis colorectal cancer type 8	C1333990	5	119	8.87979600961e-09	4.4892915980230646e-05	STK11,CDKN2A,TP53,MDM2,ATM
110	Hereditary cancer-predisposing syndrome	C0027672	4	58	1.13682840919e-08	4.5304777594728176e-05	STK11,CDKN2A,TP53,ATM
111	Intraosseous mucoepidermoid carcinoma	C0206694	4	62	1.59813963174e-08	4.5716639209225705e-05	CDKN2A,TP53,MDM2,ATM
117	Carcinoma, Pancreatic Ductal	C0887833	4	65	2.0292665992e-08	4.8187808896210875e-05	CDKN2A,TP53,MDM2,ATM
119	Sporadic Breast Carcinoma	C1336076	5	147	3.15788184491e-08	4.9011532125205934e-05	PIN1,STK11,CDKN2A,TP53,ATM
120	Familial colorectal cancer	C1333600	4	71	3.17944646167e-08	4.9423393739703464e-05	STK11,CDKN2A,TP53,MDM2
121	Lipomatosis, Multiple	C3489413	3	26	3.35589025457e-08	4.983525535420099e-05	TP53,MDM2,DYRK2
122	recurrent childhood acute lymphoblastic leukemia	C0278519	3	26	3.35589025457e-08	5.024711696869852e-05	CDKN2A,TP53,MDM2
123	hemangiopericytoma	C0018922	3	26	3.35589025457e-08	5.0658978583196046e-05	CDKN2A,TP53,MDM2
124	childhood rhabdomyosarcoma	C0220611	3	26	3.35589025457e-08	5.1070840197693575e-05	CDKN2A,TP53,MDM2
125	Experimental Organism Basal Cell Carcinoma	C3811653	6	264	3.89004742862e-08	5.1482701812191104e-05	HIPK2,ING2,STK11,CDKN2A,TP53,MDM2
131	Acute monocytic leukemia	C0023465	4	75	4.19816165165e-08	5.395387149917628e-05	CDKN2A,TP53,EP300,KAT6A
132	Familial cancer of breast	C0346153	5	155	4.32937260486e-08	5.4365733113673804e-05	STK11,TP53,EP300,MDM2,ATM
133	Liposarcoma, Dedifferentiated	C0205824	3	28	4.58414072257e-08	5.4777594728171334e-05	CDKN2A,TP53,MDM2
134	Malignant neoplasm of brain and nervous system	C0153633	5	157	4.66677572142e-08	5.518945634266886e-05	ING2,CDKN2A,TP53,MDM2,ATM
135	Premature aging syndrome	C0231341	4	78	5.1210884533e-08	5.560131795716639e-05	PIN1,CDKN2A,TP53,ATM
136	Sarcoma, Ewing	C1261473	9	829	5.65103074335e-08	5.601317957166392e-05	PIN1,ING2,CDKN2A,TP53,EP300,KAT6A,PML,MDM2,ATM
137	Rash and Dermatitis Adverse Event Associated with Chemoradiation	C1559154	4	80	5.81501210517e-08	5.642504118616145e-05	CDKN2A,TP53,MDM2,ATM
138	Bladder carcinoma	C0699885	10	1087	6.29357721493e-08	5.683690280065898e-05	HIPK2,ING2,STK11,CDKN2A,TP53,EP300,UBC,RPS27A,MDM2,ATM
139	Neoplasm of the skin	C0037286	7	438	6.57300159856e-08	5.724876441515651e-05	STK11,CDKN2A,TP53,PPP1R13B,PML,MDM2,ATM
145	Nasopharyngeal Neoplasms	C0027439	4	84	7.44523872553e-08	5.971993410214168e-05	STK11,CDKN2A,TP53,MDM2
146	Precursor Cell Lymphoblastic Leukemia-Lymphoma	C1961102	9	854	7.46140602637e-08	6.013179571663921e-05	BRD7,CDKN2A,TP53,EP300,PPP1R13B,KAT6A,PML,MDM2,ATM
147	Mucinous Adenocarcinoma	C0007130	4	86	8.38348429566e-08	6.054365733113674e-05	STK11,CDKN2A,TP53,MDM2
148	Alveolar cell carcinoma	C0007120	4	86	8.38348429566e-08	6.095551894563427e-05	STK11,TP53,DYRK2,ATM
149	Cholangitis	C0008311	3	33	9.11899034062e-08	6.13673805601318e-05	CDKN2A,TP53,ATM
150	Adenocarcinoma in Situ	C0334276	3	33	9.11899034062e-08	6.177924217462933e-05	CDKN2A,TP53,PRMT5
151	Uterine leiomyosarcoma	C0280631	3	33	9.11899034062e-08	6.219110378912686e-05	TP53,EP300,MDM2
152	{Gastric cancer risk after H. pylori infection}, 137215 (3)	C0024623	13	2073	9.33039879802e-08	6.260296540362439e-05	PIN1,ING2,TP53INP1,STK11,CDKN2A,TP53,TP53BP2,PPP1R13B,PRMT5,PML,MDM2,DYRK2,ATM
153	Therapy-related myelodysplastic syndrome	C1292780	3	34	1.03195540224e-07	6.301482701812192e-05	CDKN2A,TP53,KAT6A
154	keratoacanthoma	C0022572	3	34	1.03195540224e-07	6.342668863261943e-05	HIPK2,CDKN2A,TP53
155	Malignant neoplasm of oropharynx	C0153382	3	34	1.03195540224e-07	6.383855024711698e-05	CDKN2A,TP53,MDM2
158	Metastatic Carcinoma	C1384494	3	36	1.30849728275e-07	6.507413509060955e-05	ING5,CDKN2A,TP53
159	Stomach Neoplasms	C0038356	9	916	1.43271020825e-07	6.54859967051071e-05	TP53INP1,STK11,CDKN2A,TP53,EP300,TP53BP2,PRMT5,MDM2,ATM
160	Cancer Cell Growth	C1516170	6	320	1.44269820201e-07	6.589785831960461e-05	ING2,STK11,TP53,PML,MDM2,ATM
161	Testicular malignant germ cell tumor	C0855197	4	96	1.45696347431e-07	6.630971993410215e-05	STK11,TP53,MDM2,ATM
162	Multiple tumors	C0260037	4	96	1.45696347431e-07	6.672158154859967e-05	PIN1,CDKN2A,TP53,MDM2
163	Neoplasm by histology	C4023186	5	193	1.58781206294e-07	6.713344316309721e-05	STK11,CDKN2A,TP53,EP300,MDM2
167	Combined Hepatocellular Carcinoma and Cholangiocarcinoma	C0221287	7	497	1.72778700569e-07	6.878088962108732e-05	TP53INP1,STK11,CDKN2A,TP53,PML,RPS27A,MDM2
168	Diffuse Astrocytoma	C0280785	3	39	1.82220462719e-07	6.919275123558485e-05	CDKN2A,TP53,ATM
169	Abnormality of the nasopharynx	C4025750	4	102	1.97479029018e-07	6.960461285008237e-05	STK11,TP53,EP300,ATM
170	Gastrointestinal carcinoma	C0151544	3	41	2.2392560084e-07	7.00164744645799e-05	STK11,TP53,EP300
177	Neoplasm of the larynx	C0023055	4	106	2.3938257987e-07	7.289950576606261e-05	STK11,CDKN2A,TP53,MDM2
178	Hamartoma	C0018552	4	106	2.3938257987e-07	7.331136738056013e-05	STK11,CDKN2A,TP53,MDM2
179	precancerous lesions	C0940937	4	106	2.3938257987e-07	7.372322899505767e-05	CDKN2A,TP53,MDM2,ATM
180	Malignant Conversion	C1518171	3	42	2.47245138474e-07	7.413509060955519e-05	CDKN2A,TP53,MDM2
181	Gestational trophoblastic disease	C1135868	3	42	2.47245138474e-07	7.454695222405273e-05	TP53,TP53BP2,PPP1R13B
182	Carcinosarcoma	C0007140	3	42	2.47245138474e-07	7.495881383855024e-05	CDKN2A,TP53,MDM2
183	Teratoma	C0039538	4	108	2.62857160815e-07	7.537067545304777e-05	STK11,CDKN2A,TP53,PRMT5
184	Leukemia, Plasma Cell	C0023484	3	43	2.72396169287e-07	7.57825370675453e-05	CDKN2A,TP53,MDM2
185	Intrahepatic Cholangiocarcinoma	C0345905	4	109	2.75209480649e-07	7.619439868204283e-05	NUAK1,CDKN2A,TP53,MDM2
186	Ataxia-telangiectasia syndrome	C0004135	5	212	2.76027835255e-07	7.660626029654036e-05	CDKN2A,TP53,PML,MDM2,ATM
187	Single tumor	C1298180	3	44	2.99330268461e-07	7.701812191103789e-05	HIPK2,CDKN2A,TP53
188	Neoplasm of the adrenal gland	C0001624	4	111	3.01368087152e-07	7.742998352553542e-05	CDKN2A,TP53,MDM2,ATM
193	Hepatocellular carcinoma	C2239176	15	3108	3.24539647378e-07	7.948929159802307e-05	PIN1,HIPK2,ING2,STK11,NUAK1,CDKN2A,TP53,EP300,TP53BP2,PPP1R13B,PML,UBC,RPS27A,MDM2,ATM
194	Blast Phase	C0005699	5	221	3.52357683919e-07	7.990115321252058e-05	CDKN2A,TP53,EP300,MDM2,ATM
195	Clear cell renal cell carcinoma	C0279702	6	368	3.70738445277e-07	8.031301482701813e-05	PIN1,STK11,CDKN2A,TP53,PML,ATM
196	Neuroblastoma	C0700095	11	1612	3.82009736954e-07	8.072487644151564e-05	PIN1,HIPK2,ING2,STK11,CDKN2A,TP53,UBB,PML,MDM2,USP24,ATM
197	Breast Neoplasms	C1458155	5	225	3.91463276461e-07	8.113673805601319e-05	STK11,CDKN2A,TP53,MDM2,ATM
198	Trisomy 12	C0432408	3	47	3.92258489801e-07	8.15485996705107e-05	TP53,MDM2,ATM
205	Squamous cell carcinoma of mouth	C0585362	3	48	4.27506440692e-07	8.443163097199341e-05	CDKN2A,TP53,ATM
206	Rous Sarcoma	C0086942	3	49	4.65054973309e-07	8.484349258649095e-05	CDKN2A,UBC,RPS27A
207	Non-small cell lung carcinoma	C0007131	12	1993	4.82250420597e-07	8.525535420098847e-05	PIN1,ING2,BRD7,STK11,NUAK1,CDKN2A,TP53,EP300,PPP1R13B,PML,MDM2,ATM
208	Liposarcoma	C0023827	4	122	4.82532225621e-07	8.566721581548601e-05	CDKN2A,TP53,PML,MDM2
209	Abnormality of the large intestine	C4025715	4	123	5.02506434463e-07	8.607907742998353e-05	STK11,TP53,EP300,MDM2
210	stage, non-small cell lung cancer	C0280217	3	50	5.04990055217e-07	8.649093904448106e-05	CDKN2A,TP53,MDM2
211	Leukemia, Lymphocytic, Acute, L1	C0023452	6	388	5.29012525896e-07	8.690280065897859e-05	CDKN2A,TP53,EP300,PML,MDM2,ATM
212	Phyllodes tumor, benign	C0010701	3	51	5.47518614669e-07	8.731466227347612e-05	CDKN2A,TP53,MDM2
213	Hereditary breast and ovarian cancer syndrome	C0677776	3	51	5.47518614669e-07	8.772652388797365e-05	CDKN2A,TP53,ATM
217	Cervical Adenocarcinoma	C0279672	3	53	6.40394635099e-07	8.937397034596376e-05	STK11,CDKN2A,TP53
218	Myeloproliferative Disorders	C0027022	5	245	6.44278994155e-07	8.978583196046129e-05	STK11,CDKN2A,TP53,EP300,PML
219	Malignant tumor of urinary bladder	C0005684	10	1371	6.47194609016e-07	9.019769357495881e-05	PIN1,HIPK2,ING2,STK11,CDKN2A,TP53,UBC,RPS27A,MDM2,ATM
220	Abnormality of the pharynx	C4025838	4	130	6.61452746464e-07	9.060955518945635e-05	STK11,TP53,EP300,ATM
221	Acute lymphoid leukemia	C0023449	8	824	6.83005088931e-07	9.102141680395387e-05	CDKN2A,TP53,EP300,PPP1R13B,KAT6A,PML,MDM2,ATM
222	Nerve Sheath Tumors	C0206727	3	54	6.90964079064e-07	9.143327841845141e-05	CDKN2A,TP53,MDM2
223	Endometrial Hyperplasia	C0014173	3	54	6.90964079064e-07	9.184514003294893e-05	CDKN2A,TP53,ATM
229	Malignant gastrointestinal tract tumors	C0685938	5	251	7.41966130424e-07	9.43163097199341e-05	STK11,CDKN2A,TP53,EP300,ATM
230	Germ cell neoplasia	C0205851	5	252	7.59343734558e-07	9.472817133443163e-05	STK11,CDKN2A,TP53,PML,MDM2
231	Differentiated Thyroid Gland Carcinoma	C1337013	4	134	7.68664243367e-07	9.514003294892916e-05	CDKN2A,TP53,MDM2,ATM
232	 {Aerodigestive tract cancer, squamous cell, alcohol-related, protection against} (3)	C0751688	4	134	7.68664243367e-07	9.555189456342669e-05	PIN1,CDKN2A,TP53,MDM2
233	Malignant Glioma	C0555198	6	412	7.90586794031e-07	9.596375617792422e-05	PIN1,CDKN2A,TP53,PPP1R13B,MDM2,ATM
234	Neurofibromatosis 2	C0027832	3	56	8.0101427713e-07	9.637561779242175e-05	CDKN2A,TP53,MDM2
235	Leiomyosarcoma	C0023269	4	136	8.27196158459e-07	9.678747940691928e-05	CDKN2A,TP53,EP300,MDM2
236	Hepatic cancer metastatic	C0345904	7	613	8.44440284475e-07	9.719934102141681e-05	TP53INP1,STK11,CDKN2A,TP53,PPP1R13B,PML,MDM2
237	Malignant Fibrous Histiocytoma	C0334463	3	57	8.60738863517e-07	9.761120263591433e-05	CDKN2A,TP53,MDM2
238	Medullary carcinoma	C0206693	3	57	8.60738863517e-07	9.802306425041187e-05	TP53,MDM2,ATM
246	Testicular Neoplasms	C0039590	4	139	9.21514986651e-07	0.00010131795716639209	STK11,CDKN2A,TP53,PRMT5
247	Genitourinary neoplasm	C0042065	4	141	9.88929361512e-07	0.00010172981878088962	STK11,CDKN2A,TP53,EP300
248	Oropharyngeal Carcinoma	C2349952	3	60	1.05960599373e-06	0.00010214168039538715	CDKN2A,TP53,MDM2
253	Gastrointestinal Neoplasms	C0017185	5	268	1.08670936227e-06	0.0001042009884678748	STK11,CDKN2A,TP53,EP300,MDM2
254	Endometrial Neoplasms	C0014170	5	268	1.08670936227e-06	0.00010461285008237233	CDKN2A,TP53,EP300,MDM2,ATM
255	Glioblastoma multiforme	C1621958	6	434	1.11860017837e-06	0.00010502471169686984	CDKN2A,TP53,PRMT5,PML,MDM2,ATM
256	Primary Glioblastoma	C1514422	3	61	1.13297024651e-06	0.00010543657331136739	CDKN2A,TP53,ATM
257	Hydatidiform mole, recurrent, 1, 231090 (3)	C3463897	3	62	1.21001106779e-06	0.0001058484349258649	TP53,TP53BP2,PPP1R13B
258	Malignant tumor of cervix	C0007847	8	889	1.28294190371e-06	0.00010626029654036244	PIN1,STK11,CDKN2A,TP53,UBB,PML,MDM2,ATM
259	Colorectal Neoplasms	C0009404	9	1164	1.28970003666e-06	0.00010667215815485996	PIN1,STK11,CDKN2A,TP53,EP300,TP53BP2,PML,MDM2,ATM
260	Persistent infection	C1264606	3	63	1.29086484379e-06	0.0001070840197693575	CDKN2A,TP53,ATM
268	Pharyngeal Neoplasms	C0031347	3	64	1.37562876046e-06	0.00011037891268533773	CDKN2A,TP53,MDM2
269	gliosarcoma	C0206726	3	64	1.37562876046e-06	0.00011079077429983526	CDKN2A,TP53,MDM2
270	Ameloblastoma	C0002448	3	65	1.46452036998e-06	0.00011120263591433279	CDKN2A,TP53,MDM2
271	Lipoma	C0023798	3	65	1.46452036998e-06	0.00011161449752883033	TP53,MDM2,DYRK2
272	Neuroepithelial neoplasm	C0206715	3	65	1.46452036998e-06	0.00011202635914332784	CDKN2A,TP53,MDM2
273	Invasive Carcinoma	C1334274	4	154	1.52815378918e-06	0.00011243822075782537	CDKN2A,TP53,PML,MDM2
325	Triple Negative Breast Neoplasms	C3539878	6	461	1.67057453715e-06	0.00013385502471169685	PIN1,BRD7,CDKN2A,TP53,MDM2,ATM
326	Squamous cell carcinoma	C0007137	11	1855	1.70444699465e-06	0.00013426688632619442	PIN1,HIPK2,ING2,BRD7,STK11,CDKN2A,TP53,EP300,PML,MDM2,ATM
327	Carcinoma of colon	C0699790	11	1856	1.71416478378e-06	0.00013467874794069194	HIPK2,STK11,CDKN2A,TP53,EP300,PPP1R13B,NOC2L,PML,RPS27A,MDM2,ATM
328	Urinary Bladder Neoplasms	C0005695	6	463	1.71927136072e-06	0.00013509060955518945	STK11,CDKN2A,TP53,EP300,MDM2,ATM
329	Carcinoma, Large Cell	C0206704	3	68	1.75685913995e-06	0.00013550247116968697	STK11,CDKN2A,TP53
330	Occupational Diseases	C0028797	3	68	1.75685913995e-06	0.00013591433278418451	CDKN2A,TP53,MDM2
331	Hemangiosarcoma	C0018923	3	68	1.75685913995e-06	0.00013632619439868206	CDKN2A,TP53,MDM2
332	Adrenocortical carcinoma	C0206686	4	160	1.8444340264e-06	0.00013673805601317957	CDKN2A,TP53,PML,ATM
338	Progressive Neoplastic Disease	C0677932	4	161	1.90178489889e-06	0.00013920922570016475	PIN1,CDKN2A,TP53,MDM2
339	Progressive cGVHD	C3539781	4	161	1.90178489889e-06	0.00013962108731466227	PIN1,CDKN2A,TP53,MDM2
340	Hepatocarcinogenesis	C1512409	6	471	1.92590309367e-06	0.0001400329489291598	PIN1,ING2,STK11,CDKN2A,TP53,MDM2
341	Osteosarcoma	C0585442	8	936	1.96244682815e-06	0.00014044481054365735	ING2,BRD7,CDKN2A,TP53,NOC2L,PML,MDM2,ATM
342	Nasopharyngeal cancer recurrent	C0153392	3	70	1.97440273275e-06	0.00014085667215815487	CDKN2A,TP53,MDM2
343	T-cell lymphoma	C0079772	5	302	2.17113943235e-06	0.00014126853377265238	NUAK1,CDKN2A,TP53,EP300,ATM
354	Peutz-Jeghers syndrome	C0031269	3	73	2.3373986342e-06	0.00014579901153212522	STK11,CDKN2A,TP53
355	Polyposis syndrome, mixed hereditary 1 (4)	C0334108	3	74	2.46869964204e-06	0.00014621087314662274	STK11,CDKN2A,TP53
362	Uterine Cervical Neoplasms	C0007873	4	171	2.55659476167e-06	0.00014909390444810546	STK11,CDKN2A,TP53,MDM2
363	Oral leukoplakia	C0023532	3	75	2.60542118191e-06	0.00014950576606260297	CDKN2A,TP53,ATM
364	Uterine neoplasm	C0042138	3	77	2.89562831635e-06	0.0001499176276771005	STK11,TP53,EP300
365	Chronic gastritis	C0085695	3	77	2.89562831635e-06	0.00015032948929159803	ING2,CDKN2A,TP53
372	Endometrial carcinoma	C0476089	7	726	2.979718847e-06	0.00015321252059308072	BRD7,STK11,CDKN2A,TP53,EP300,MDM2,ATM
373	Thyroid cancer, follicular	C0206682	4	177	3.02724063517e-06	0.00015362438220757827	HIPK2,CDKN2A,TP53,ATM
374	Huntington's chorea	C0020179	5	320	3.03160940818e-06	0.00015403624382207578	CDKN2A,TP53,UBC,RPS27A,ATM
375	Protein Deficiency	C0033626	3	78	3.04936492368e-06	0.0001544481054365733	CDKN2A,TP53,ATM
376	pediatric acute myeloblastic leukemia	C0220621	3	78	3.04936492368e-06	0.00015485996705107084	TP53,PML,MDM2
377	Uterine Corpus Cancer	C0153574	6	506	3.0920318056e-06	0.00015527182866556839	STK11,CDKN2A,TP53,EP300,MDM2,ATM
378	Malignant neoplasm of endometrium	C0007103	6	506	3.0920318056e-06	0.0001556836902800659	STK11,CDKN2A,TP53,EP300,MDM2,ATM
379	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 4	C1140680	11	1967	3.15371344706e-06	0.00015609555189456342	HIPK2,BRD7,STK11,CDKN2A,TP53,EP300,NOC2L,PML,MDM2,DYRK2,ATM
380	Benign melanocytic nevus	C1456781	3	80	3.37486962709e-06	0.00015650741350906096	CDKN2A,TP53,MDM2
381	M5b Acute differentiated monocytic leukemia	C1318544	3	80	3.37486962709e-06	0.0001569192751235585	TP53,EP300,KAT6A
387	Malignant neoplasm of pancreas	C0346647	10	1625	3.42584068802e-06	0.00015939044481054365	BRD7,TP53INP1,STK11,ING5,NUAK1,CDKN2A,TP53,EP300,MDM2,ATM
388	Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse	C0334634	5	327	3.43353515575e-06	0.00015980230642504117	CDKN2A,TP53,PRMT5,MDM2,ATM
389	Hydatidiform mole, recurrent, 2	C0020217	3	82	3.72551819661e-06	0.00016021416803953874	TP53,TP53BP2,PPP1R13B
390	Melanocytic nevus	C0027962	4	185	3.7578208415e-06	0.00016062602965403626	STK11,CDKN2A,TP53,MDM2
391	Carcinogenesis	C0596263	15	3723	3.79793243588e-06	0.00016103789126853377	PIN1,HIPK2,ING2,BRD7,TP53INP1,STK11,ING5,CDKN2A,TP53,EP300,TTC5,PRMT5,PML,MDM2,ATM
392	Metastatic melanoma	C0278883	5	333	3.81162233942e-06	0.0001614497528830313	STK11,NUAK1,CDKN2A,TP53,MDM2
397	Lichen Planus, Oral	C0206139	3	83	3.91064735528e-06	0.00016350906095551895	CDKN2A,TP53,ATM
398	Acute leukemia	C0085669	6	525	3.94046185492e-06	0.0001639209225700165	CDKN2A,TP53,TP53BP2,KAT6A,PML,ATM
399	Genital neoplasm	C0679347	3	85	4.30106908655e-06	0.000164332784184514	STK11,TP53,EP300
400	Post-transplant lymphoproliferative disorder	C0432487	2	25	4.40091219189e-06	0.00016474464579901152	CDKN2A,TP53
401	Shwachman syndrome	C0272170	2	25	4.40091219189e-06	0.00016515650741350907	TP53,ATM
402	Neoplasms, Radiation-Induced	C0027666	2	25	4.40091219189e-06	0.00016556836902800658	TP53,ATM
403	Fibromyxosarcoma	C3714524	2	25	4.40091219189e-06	0.00016598023064250413	TP53,MDM2
404	Squamous cell carcinoma of lung	C0149782	4	192	4.5048616818e-06	0.00016639209225700164	STK11,CDKN2A,TP53,MDM2
405	Soft Tissue Neoplasms	C0037579	3	86	4.50684941089e-06	0.00016680395387149918	CDKN2A,TP53,MDM2
406	Congenital chromosomal disease	C0008626	6	537	4.57047050584e-06	0.0001672158154859967	CDKN2A,TP53,KAT6A,PML,MDM2,ATM
407	Neoplasms, Second Primary	C0085183	4	193	4.62048207694e-06	0.00016762767710049424	CDKN2A,TP53,PML,MDM2
408	Primary cutaneous marginal zone B-cell lymphoma	C0242647	4	193	4.62048207694e-06	0.0001680395387149918	CDKN2A,TP53,MDM2,ATM
460	Carcinoma of cervix	C0302592	8	1045	4.83168149956e-06	0.00018945634266886327	PIN1,STK11,CDKN2A,TP53,UBB,PML,MDM2,ATM
461	Pilocytic Astrocytoma	C0334583	3	88	4.94003775275e-06	0.0001898682042833608	HIPK2,CDKN2A,TP53
462	Lafora disease	C0751783	2	26	4.97052090576e-06	0.00019028006589785832	HIPK2,TP53
463	Plasmablastic lymphoma	C0079746	2	26	4.97052090576e-06	0.00019069192751235584	CDKN2A,ATM
464	Malignant neoplasm of adrenal cortex	C0346402	2	26	4.97052090576e-06	0.00019110378912685338	CDKN2A,TP53
465	Inappropriate ADH Syndrome	C1332347	2	26	4.97052090576e-06	0.0001915156507413509	CDKN2A,TP53
466	Oropharynx (excludes nasopharynx)	C0521367	2	26	4.97052090576e-06	0.00019192751235584844	CDKN2A,TP53
467	Vestibular Schwannoma	C0027859	3	89	5.1677762033e-06	0.00019233937397034596	CDKN2A,TP53,MDM2
468	Alzheimer Disease	C0002395	10	1699	5.26627817199e-06	0.0001927512355848435	PIN1,STK11,CDKN2A,TP53,EP300,TP53BP2,UBB,PRMT5,PML,ATM
469	 Adenocarcinoma, ovarian, somatic, 167000 (3)	C0001418	10	1700	5.29621499612e-06	0.00019316309719934102	ING2,STK11,CDKN2A,TP53,PRMT5,PML,UBC,MDM2,DYRK2,ATM
470	Oral Cavity Carcinoma	C0151546	3	90	5.40324149056e-06	0.00019357495881383856	CDKN2A,TP53,MDM2
471	Adult Acute Myeloblastic Leukemia	C0220615	3	90	5.40324149056e-06	0.00019398682042833608	CDKN2A,TP53,MDM2
472	Acute type B viral hepatitis	C0019163	7	790	5.55253257994e-06	0.00019439868204283362	PIN1,CDKN2A,TP53,TP53BP2,PPP1R13B,PML,MDM2
473	Febrile Neutropenia	C0746883	2	27	5.58688808272e-06	0.00019481054365733114	TP53,MDM2
474	Gallbladder adenocarcinoma	C0279651	2	27	5.58688808272e-06	0.00019522240527182865	CDKN2A,TP53
475	Abnormality of male internal genitalia	C4025899	2	27	5.58688808272e-06	0.00019563426688632622	TP53,EP300
476	Cervical dysplasia	C0007868	2	27	5.58688808272e-06	0.00019604612850082374	CDKN2A,TP53
477	Seborrheic keratosis	C0022603	2	27	5.58688808272e-06	0.00019645799011532125	CDKN2A,TP53
478	Bone neoplasms	C0005967	3	91	5.64651796653e-06	0.00019686985172981877	TP53,NOC2L,MDM2
479	DNA Damage	C0012860	3	91	5.64651796653e-06	0.00019728171334431634	TP53,MDM2,ATM
480	Actinic keratosis	C0022602	3	91	5.64651796653e-06	0.00019769357495881386	HIPK2,CDKN2A,TP53
481	X-linked ichthyosis with steryl-sulfatase deficiency	C0079588	3	92	5.89788478278e-06	0.00019810543657331137	CDKN2A,TP53,MDM2
482	Death, Sudden, Cardiac	C0011065	4	203	5.90935247702e-06	0.0001985172981878089	PIN1,TP53,MDM2,ATM
483	Renal neoplasm	C0022665	5	363	6.24701391172e-06	0.00019892915980230643	STK11,CDKN2A,TP53,EP300,MDM2
484	Malignant neoplasm of vulva	C0375071	2	28	6.25182922787e-06	0.00019934102141680397	CDKN2A,TP53
485	Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma	C0079744	6	568	6.59801880687e-06	0.0001997528830313015	CDKN2A,TP53,EP300,TP53BP2,MDM2,ATM
486	Skin carcinoma	C0699893	3	95	6.70152839299e-06	0.000200164744645799	CDKN2A,TP53,MDM2
487	Invasive breast carcinoma	C0853879	5	369	6.85989074012e-06	0.00020057660626029655	STK11,CDKN2A,TP53,MDM2,ATM
488	Dermatofibrosarcoma protuberans	C0392784	2	29	6.96705777004e-06	0.0002009884678747941	TP53,MDM2
489	Burkitt lymphoma	C0006413	4	210	6.96785259524e-06	0.0002014003294892916	CDKN2A,TP53,EP300,MDM2
490	Adenocarcinoma of lung	C0152013	7	815	6.97590781662e-06	0.00020181219110378912	STK11,CDKN2A,TP53,TTC5,PRMT5,MDM2,ATM
491	Neoplasm by anatomical site	C4023185	6	576	7.22818827481e-06	0.00020222405271828667	STK11,CDKN2A,TP53,EP300,MDM2,ATM
492	Biliary Tract Cancer	C0750952	3	97	7.28047622622e-06	0.00020263591433278418	STK11,CDKN2A,TP53
493	Abnormality of the pancreas	C4025751	4	212	7.29606588712e-06	0.00020304777594728173	STK11,CDKN2A,TP53,MDM2
494	Cervical intraepithelial neoplasia (Cervical dysplasia)	C0206708	4	212	7.29606588712e-06	0.00020345963756177924	CDKN2A,TP53,MDM2,ATM
495	Benign neoplasm of other endocrine glands	C0086692	4	213	7.46463654488e-06	0.00020387149917627678	CDKN2A,TP53,MDM2,ATM
496	Colorectal cancer 1	C0009402	12	2543	7.51475089567e-06	0.0002042833607907743	PIN1,HIPK2,ING2,TP53INP1,STK11,NUAK1,CDKN2A,TP53,EP300,TP53BP2,MDM2,ATM
497	Hyperplastic Polyp	C0333983	3	98	7.58343076068e-06	0.00020469522240527184	STK11,CDKN2A,TP53
498	Squamous cell carcinoma of the head and neck	C1168401	7	825	7.62614736449e-06	0.00020510708401976936	PIN1,ING2,STK11,CDKN2A,TP53,MDM2,ATM
499	T-Cell Prolymphocytic Leukemia	C0023494	2	30	7.73436975154e-06	0.0002055189456342669	TP53,ATM
500	Thymic Carcinoma	C1322286	2	30	7.73436975154e-06	0.00020593080724876442	CDKN2A,TP53
501	Verrucae	C0043037	2	30	7.73436975154e-06	0.00020634266886326193	TP53,MDM2
502	Gastric Mucosa-Associated Lymphoid Tissue Lymphoma	C1333782	2	30	7.73436975154e-06	0.00020675453047775948	CDKN2A,TP53
503	Avellino corneal dystrophy	C1275685	2	30	7.73436975154e-06	0.00020716639209225702	CDKN2A,TP53
504	Large cell neuroendocrine carcinoma	C1265996	2	30	7.73436975154e-06	0.00020757825370675454	CDKN2A,TP53
505	Meningioma, benign, no ICD-O subtype	C1762616	4	217	8.16962941841e-06	0.00020799011532125205	CDKN2A,TP53,MDM2,ATM
506	Spastic syndrome	C0270814	3	100	8.21711475418e-06	0.0002084019769357496	TP53,PML,ATM
507	Epstein-Barr Virus Infections	C0149678	4	219	8.54117733573e-06	0.00020881383855024714	CDKN2A,TP53,MDM2,ATM
508	Leukoencephalopathy, Progressive Multifocal	C0023524	3	101	8.54816019968e-06	0.00020922570016474465	HIPK2,TP53,PML
509	Lichen Sclerosus et Atrophicus	C0023652	2	31	8.5555279834e-06	0.00020963756177924217	CDKN2A,TP53
510	Gallbladder Diseases	C0016977	2	31	8.5555279834e-06	0.00021004942339373969	CDKN2A,TP53
511	Chronic leukemia	C1279296	2	31	8.5555279834e-06	0.00021046128500823726	CDKN2A,ATM
512	Ovarian epithelial cancer	C0677886	11	2172	8.80688266125e-06	0.00021087314662273477	HIPK2,BRD7,STK11,CDKN2A,TP53,EP300,NOC2L,PML,MDM2,DYRK2,ATM
513	Skin cancer	C0007114	4	222	9.12311371204e-06	0.0002112850082372323	STK11,CDKN2A,TP53,MDM2
514	Ductal Carcinoma	C1527349	4	223	9.32383857255e-06	0.0002116968698517298	CDKN2A,TP53,PML,ATM
515	Epidermolysis bullosa, junctional	C0014527	2	32	9.43231239825e-06	0.00021210873146622737	TP53,RPS27A
516	Gastrinoma	C0017150	2	32	9.43231239825e-06	0.0002125205930807249	CDKN2A,TP53
517	Adult Acute Lymphocytic Leukemia	C0751606	3	104	9.60067054601e-06	0.0002129324546952224	CDKN2A,TP53,ATM
549	Neoplasm of the oral cavity	C0026640	4	226	9.94679535127e-06	0.00022611202635914332	CDKN2A,TP53,MDM2,ATM
550	Posttraumatic stress disorder	C0038436	3	106	1.03535132032e-05	0.00022652388797364087	TP53,EP300,MDM2
551	Primary Lesion	C1402294	2	33	1.03664426016e-05	0.0002269357495881384	CDKN2A,TP53
552	Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome	C1332153	2	33	1.03664426016e-05	0.00022734761120263592	CDKN2A,TP53
553	Aggressive Non-Hodgkin Lymphoma	C1332225	2	33	1.03664426016e-05	0.00022775947281713344	TP53,ATM
554	Recessive dystrophic epidermolysis bullosa	C0079474	2	33	1.03664426016e-05	0.00022817133443163098	CDKN2A,TP53
555	Follicular neoplasm	C0474808	2	33	1.03664426016e-05	0.0002285831960461285	CDKN2A,TP53
556	Secondary malignant neoplasm of lung	C0153676	6	614	1.09495192975e-05	0.00022899505766062604	TP53INP1,STK11,NUAK1,CDKN2A,TP53,MDM2
557	Hematological neoplasm	C0376545	6	615	1.10655994863e-05	0.00022940691927512356	CDKN2A,TP53,EP300,PML,MDM2,ATM
558	Inflammatory Myofibroblastic Tumor	C0334121	2	34	1.13596054373e-05	0.0002298187808896211	TP53,MDM2
559	Acinar Cell Carcinoma	C0206685	2	34	1.13596054373e-05	0.00023023064250411862	STK11,TP53
560	Cervix Diseases	C0007867	2	34	1.13596054373e-05	0.00023064250411861616	CDKN2A,TP53
561	Comedone	C0221228	2	34	1.13596054373e-05	0.00023105436573311368	TP53,ATM
562	Carcinoma, Papillary	C0007133	4	233	1.15273218552e-05	0.00023146622734761122	CDKN2A,TP53,MDM2,ATM
563	Mixed Salivary Gland Tumor	C0026277	3	109	1.15632858708e-05	0.00023187808896210873	CDKN2A,TP53,MDM2
564	Skin Carcinogenesis	C1519346	3	110	1.19887689927e-05	0.00023228995057660625	CDKN2A,TP53,PML
565	Hodgkin Disease	C0019829	5	409	1.23151416269e-05	0.0002327018121911038	CDKN2A,TP53,PML,MDM2,ATM
566	Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor	C3536893	2	35	1.24137018057e-05	0.00023311367380560134	CDKN2A,TP53
567	Gastritis	C0017152	4	237	1.25147752494e-05	0.00023352553542009885	TP53INP1,CDKN2A,TP53,ATM
568	Abnormal breast morphology	C0742257	4	238	1.27716792628e-05	0.00023393739703459637	STK11,CDKN2A,TP53,MDM2
569	Hypergranular promyelocytic leukemia	C2745900	4	238	1.27716792628e-05	0.0002343492586490939	PIN1,HIPK2,TP53,PML
570	Colorectal cancer	C1527249	12	2681	1.34127283442e-05	0.00023476112026359145	PIN1,HIPK2,ING2,TP53INP1,STK11,NUAK1,CDKN2A,TP53,EP300,TP53BP2,MDM2,ATM
571	Abnormality of the breast	C4025829	4	242	1.38407125007e-05	0.00023517298187808897	STK11,CDKN2A,TP53,MDM2
572	Urinary tract neoplasm	C0042076	3	115	1.42915431397e-05	0.0002355848434925865	STK11,TP53,EP300
573	Spinocerebellar ataxia 7	C0752125	2	37	1.47112190818e-05	0.000235996705107084	TP53,PML
574	Mammary adenocarcinoma	C3669246	2	37	1.47112190818e-05	0.00023640856672158157	CDKN2A,TP53
575	Condylomata Acuminata	C0009663	2	37	1.47112190818e-05	0.0002368204283360791	CDKN2A,TP53
576	Costello syndrome	C0587248	2	37	1.47112190818e-05	0.0002372322899505766	CDKN2A,TP53
577	Juvenile myelomonocytic leukemia	C0349639	3	116	1.47885412715e-05	0.00023764415156507412	CDKN2A,TP53,PPP1R13B
578	Chronic atrophic gastritis	C0017154	3	116	1.47885412715e-05	0.0002380560131795717	CDKN2A,TP53,MDM2
579	Neoplasms	C0027651	6	646	1.52080276252e-05	0.0002384678747940692	STK11,CDKN2A,TP53,EP300,MDM2,ATM
621	B-cell lymphoma	C0079731	6	652	1.61422203611e-05	0.00025576606260296545	CDKN2A,TP53,EP300,PRMT5,MDM2,ATM
622	Cancer of Head and Neck	C0278996	5	430	1.63454198077e-05	0.00025617792421746293	STK11,CDKN2A,TP53,MDM2,ATM
623	Xeroderma pigmentosum, group E	C0043346	3	119	1.63560230463e-05	0.0002565897858319605	CDKN2A,TP53,MDM2
624	Malignant tumor of testis	C0153594	4	251	1.65018049681e-05	0.00025700164744645797	STK11,TP53,MDM2,ATM
625	Lymphoid leukemia	C0023448	4	252	1.68204493592e-05	0.0002574135090609555	CDKN2A,TP53,TP53BP2,ATM
626	Gastric Cardia Adenocarcinoma	C1333762	2	39	1.72728286183e-05	0.00025782537067545305	TP53,MDM2
627	Prostate cancer stage C	C0280280	2	39	1.72728286183e-05	0.0002582372322899506	TP53,ATM
628	Ependymoma	C0014474	3	121	1.74668448721e-05	0.00025864909390444814	CDKN2A,TP53,MDM2
629	Primary Effusion Lymphoma	C1292753	3	121	1.74668448721e-05	0.0002590609555189456	CDKN2A,TP53,MDM2
630	Cutaneous T-cell lymphoma	C0079773	4	255	1.78053652062e-05	0.00025947281713344317	CDKN2A,TP53,MDM2,ATM
631	Tauopathies	C0949664	3	123	1.86321648853e-05	0.0002598846787479407	PIN1,TP53,UBB
632	Multiple Myeloma	C0026764	8	1236	1.86373819783e-05	0.0002602965403624382	STK11,NUAK1,CDKN2A,TP53,PPP1R13B,MDM2,USP24,ATM
633	Stromal sarcoma	C0206630	2	40	1.86568706158e-05	0.00026070840197693574	MEAF6,TP53
634	Granulomatosis	C0521173	2	40	1.86568706158e-05	0.00026112026359143323	TP53,MDM2
635	Alcoholic Steatohepatitis	C2718067	2	40	1.86568706158e-05	0.00026153212520593083	STK11,TP53
636	Neurofibromatoses	C0162678	2	40	1.86568706158e-05	0.0002619439868204284	CDKN2A,TP53
637	Prolymphocytic Leukemia	C0023486	2	40	1.86568706158e-05	0.00026235584843492586	TP53,ATM
638	Carcinogenicity	C0858970	2	40	1.86568706158e-05	0.0002627677100494234	CDKN2A,TP53
639	Nasopharyngeal carcinoma, susceptibility to, 3	C2931822	6	671	1.94202090716e-05	0.00026317957166392095	BRD7,CDKN2A,TP53,PML,MDM2,ATM
640	Astrocytoma	C0004114	6	674	1.99848950084e-05	0.00026359143327841844	HIPK2,CDKN2A,TP53,PRMT5,MDM2,ATM
641	Bronchogenic Carcinoma	C0007121	2	41	2.01121547295e-05	0.000264003294892916	TP53,MDM2
642	Neoplasm of the tongue	C0040411	2	41	2.01121547295e-05	0.00026441515650741347	CDKN2A,TP53
643	Classical Hodgkin's Lymphoma	C1333064	3	126	2.04859943286e-05	0.00026482701812191107	TP53,PML,MDM2
644	Abnormality of the stomach	C4025699	4	263	2.06528297592e-05	0.0002652388797364086	STK11,CDKN2A,TP53,EP300
645	Primary biliary cirrhosis	C0008312	4	263	2.06528297592e-05	0.0002656507413509061	CDKN2A,TP53,PML,ATM
646	Cutaneous malignant melanoma 3	C0151779	4	264	2.10322821989e-05	0.00026606260296540364	STK11,CDKN2A,TP53,MDM2
647	Papillary thyroid carcinoma	C0238463	5	451	2.1382356633e-05	0.00026647446457990113	STK11,CDKN2A,TP53,MDM2,ATM
648	Tumor Progression	C0178874	10	1969	2.13948002051e-05	0.0002668863261943987	PIN1,HIPK2,ING2,STK11,NUAK1,CDKN2A,TP53,PML,MDM2,ATM
649	Angiofibromas	C0206731	2	42	2.16402014069e-05	0.0002672981878088962	TP53,MDM2
650	Chemical Carcinogenesis	C0596321	2	42	2.16402014069e-05	0.0002677100494233937	CDKN2A,TP53
651	Primary malignant neoplasm of brain	C0750979	2	42	2.16402014069e-05	0.0002681219110378913	CDKN2A,TP53
652	Meningioma	C0025286	5	452	2.16503237119e-05	0.00026853377265238885	ING2,CDKN2A,TP53,MDM2,ATM
653	Thyroid cancer, nonmedullary, 4	C0007115	5	453	2.19209592294e-05	0.00026894563426688633	HIPK2,CDKN2A,TP53,MDM2,ATM
654	Cervical Squamous Cell Carcinoma	C0279671	3	129	2.24721508387e-05	0.0002693574958813839	STK11,CDKN2A,TP53
655	Ewing's sarcoma	C0553580	4	268	2.26049278953e-05	0.00026976935749588137	CDKN2A,TP53,TTC5,MDM2
656	Ovarian epithelial cancer stage III	C0280220	2	43	2.32428329283e-05	0.0002701812191103789	TP53,MDM2
657	Acute kidney injury	C0022660	4	270	2.34248408784e-05	0.00027059308072487645	CDKN2A,TP53,MDM2,ATM
694	Glioma	C0017638	10	1997	2.44206621403e-05	0.000285831960461285	PIN1,ING2,BRD7,TP53INP1,STK11,CDKN2A,TP53,PRMT5,MDM2,ATM
695	Intraepithelial Neoplasia	C0878500	3	132	2.45962235705e-05	0.00028624382207578255	CDKN2A,TP53,ATM
696	Schwannoma	C0027809	3	132	2.45962235705e-05	0.00028665568369028003	CDKN2A,TP53,MDM2
697	Transitional cell carcinoma of the bladder	C0279680	3	132	2.45962235705e-05	0.0002870675453047776	CDKN2A,TP53,EP300
698	Cystadenoma	C0010633	2	44	2.49215973581e-05	0.0002874794069192752	CDKN2A,TP53
699	Primary Carcinoma	C1335475	2	44	2.49215973581e-05	0.00028789126853377266	CDKN2A,TP53
700	Cervical intraepithelial neoplasia grade 1	C0349458	2	44	2.49215973581e-05	0.0002883031301482702	CDKN2A,TP53
701	Monocytic leukemia	C0598894	2	44	2.49215973581e-05	0.0002887149917627677	TP53,KAT6A
702	Metastatic malignant neoplasm to brain	C0220650	3	133	2.53358701416e-05	0.00028912685337726524	STK11,CDKN2A,TP53
703	Malignant neoplasm of larynx	C0007107	3	133	2.53358701416e-05	0.0002895387149917628	CDKN2A,TP53,MDM2
704	Laryngeal Squamous Cell Carcinoma	C0280324	3	134	2.60918512311e-05	0.00028995057660626027	CDKN2A,TP53,MDM2
705	Superficial ulcer	C0333307	3	134	2.60918512311e-05	0.0002903624382207578	CDKN2A,TP53,ATM
706	Capillary hemangiomas	C0206733	2	45	2.66782336318e-05	0.0002907742998352554	TP53,EP300
707	Hereditary cutaneous melanoma	C1512419	2	45	2.66782336318e-05	0.0002911861614497529	CDKN2A,TP53
708	Fuchs' Endothelial Dystrophy	C0016781	2	45	2.66782336318e-05	0.00029159802306425044	CDKN2A,TP53
709	Ganglioglioma	C0206716	2	45	2.66782336318e-05	0.00029200988467874793	CDKN2A,TP53
710	Pituitary corticotropic cell adenoma	C1306214	2	45	2.66782336318e-05	0.0002924217462932455	CDKN2A,TP53
711	Oropharyngeal disorders	C0553694	2	45	2.66782336318e-05	0.000292833607907743	CDKN2A,TP53
712	Anaplastic Oligodendroglioma	C0334590	3	135	2.68641921809e-05	0.0002932454695222405	CDKN2A,TP53,MDM2
713	Choriocarcinoma	C0008497	4	279	2.74051494291e-05	0.00029365733113673805	TP53,TP53BP2,PPP1R13B,MDM2
714	Liver Neoplasms, Experimental	C0023904	3	136	2.76532146444e-05	0.0002940691927512356	TP53,KAT6A,PML
715	Anaplastic astrocytoma	C0334579	3	137	2.8459065773e-05	0.00029448105436573314	CDKN2A,TP53,MDM2
716	Neoplasm of the respiratory system	C0035244	2	46	2.85145068353e-05	0.0002948929159802307	STK11,TP53
717	CARCINOMA OF VULVA	C0677055	2	46	2.85145068353e-05	0.00029530477759472817	CDKN2A,TP53
718	polyps	C0032584	4	284	2.98329302636e-05	0.0002957166392092257	STK11,CDKN2A,TP53,MDM2
719	Neoplasm of the nervous system	C0027766	3	139	3.0122394426e-05	0.0002961285008237232	CDKN2A,TP53,MDM2
720	Melanocytic nevus of skin	C3665593	2	47	3.04319587608e-05	0.00029654036243822074	CDKN2A,TP53
721	Mammary Tumorigenesis	C1512981	3	141	3.18558863885e-05	0.0002969522240527183	CDKN2A,TP53,MDM2
722	Neck Neoplasms	C0027533	2	48	3.24322391229e-05	0.00029736408566721583	CDKN2A,TP53
723	Bile duct cancer resectable	C0740277	2	48	3.24322391229e-05	0.00029777594728171337	CDKN2A,TP53
724	Poorly differentiated carcinoma	C0741899	2	48	3.24322391229e-05	0.0002981878088962109	CDKN2A,TP53
725	Thyroid Neoplasms	C0040136	5	486	3.25103842715e-05	0.0002985996705107084	PIN1,CDKN2A,TP53,MDM2,ATM
726	Prostatic Intraepithelial Neoplasias	C0282612	3	142	3.27495694677e-05	0.00029901153212520595	PIN1,TP53,PML
755	Cervical intraepithelial neoplasia grade 2	C0349459	2	49	3.45170309191e-05	0.00031095551894563426	CDKN2A,TP53
756	Neoplasm of the gallbladder	C0016978	2	49	3.45170309191e-05	0.0003113673805601318	CDKN2A,TP53
757	Hepatocellular adenoma	C0206669	2	49	3.45170309191e-05	0.00031177924217462935	CDKN2A,TP53
758	Ganglioneuroblastoma	C0206718	2	49	3.45170309191e-05	0.00031219110378912684	TP53,MDM2
759	Pancreatic Carcinoma	C0235974	9	1690	3.47244363182e-05	0.0003126029654036244	BRD7,TP53INP1,STK11,ING5,NUAK1,CDKN2A,TP53,MDM2,ATM
760	Neoplasm of the central nervous system	C0085136	3	145	3.55410152991e-05	0.0003130148270181219	CDKN2A,TP53,PML
761	Malignant neoplasm of tongue	C0153349	2	50	3.66879681973e-05	0.00031342668863261946	CDKN2A,TP53
762	Bloom syndrome	C0005859	2	51	3.89467979759e-05	0.000313838550247117	TP53,ATM
763	Malignant neoplasm of female breast	C0235653	2	51	3.89467979759e-05	0.0003142504118616145	CDKN2A,TP53
764	Agenesis of corpus callosum	C0175754	4	301	3.93607718389e-05	0.00031466227347611204	CDKN2A,TP53,EP300,ATM
765	Lehman syndrome	C1851710	2	52	4.12949869112e-05	0.0003150741350906096	CDKN2A,TP53
766	Squamous intraepithelial lesion	C0333873	2	52	4.12949869112e-05	0.00031548599670510707	CDKN2A,TP53
767	Neoplasm of the skeletal system	C2732838	2	52	4.12949869112e-05	0.0003158978583196046	TP53,MDM2
768	Nervous tissue neoplasm	C0027665	2	52	4.12949869112e-05	0.0003163097199341021	CDKN2A,TP53
769	Meningeal Neoplasms	C0025284	2	52	4.12949869112e-05	0.0003167215815485997	TP53,ATM
770	Sezary Syndrome	C0036920	3	151	4.16418544925e-05	0.00031713344316309724	CDKN2A,TP53,MDM2
771	Malignant peripheral nerve sheath tumor with rhabdomyoblastic differentiation	C0751690	3	151	4.16418544925e-05	0.00031754530477759473	CDKN2A,TP53,MDM2
772	Colon cancer	C0007102	9	1727	4.17980700075e-05	0.0003179571663920923	HIPK2,STK11,CDKN2A,TP53,EP300,NOC2L,PML,MDM2,ATM
773	Neurofibromas	C0027830	2	53	4.37342940902e-05	0.00031836902800658976	CDKN2A,TP53
774	Carcinoma in situ of uterine cervix	C0851140	2	53	4.37342940902e-05	0.0003187808896210873	CDKN2A,TP53
804	Gorlin syndrome	C0004779	2	54	4.62662228644e-05	0.00033113673805601316	STK11,TP53
805	Low Grade Squamous Intraepithelial Neoplasia	C1302773	2	54	4.62662228644e-05	0.0003315485996705107	CDKN2A,TP53
806	Tongue Carcinoma	C0558353	2	54	4.62662228644e-05	0.00033196046128500825	CDKN2A,TP53
807	pathologic fistula	C0016169	2	54	4.62662228644e-05	0.00033237232289950574	CDKN2A,TP53
808	Female Breast Carcinoma	C0007104	2	54	4.62662228644e-05	0.0003327841845140033	CDKN2A,TP53
809	Carcinoma, Neuroendocrine	C0206695	2	55	4.88924980271e-05	0.0003331960461285008	CDKN2A,TP53
810	Pneumonitis	C3714636	2	55	4.88924980271e-05	0.00033360790774299837	TP53,ATM
811	Diabetes insipidus	C0011848	2	55	4.88924980271e-05	0.0003340197693574959	TP53,UBB
812	Nonalcoholic Steatohepatitis	C3241937	3	158	4.96905080695e-05	0.0003344316309719934	PIN1,STK11,TP53
813	Abnormal uterus morphology	C0266383	3	158	4.96905080695e-05	0.00033484349258649094	STK11,TP53,EP300
814	Arnold-Chiari malformation	C0003803	2	56	5.16146322109e-05	0.0003352553542009885	TP53,MDM2
815	Multiple endocrine neoplasia, type 4	C0027662	2	56	5.16146322109e-05	0.000335667215815486	CDKN2A,TP53
816	Myxoid liposarcoma	C0206634	2	56	5.16146322109e-05	0.0003360790774299836	TP53,MDM2
817	Sicca Syndrome	C0086981	2	56	5.16146322109e-05	0.00033649093904448106	CDKN2A,TP53
818	Herpes Simplex Infections	C0019348	5	529	5.21223632074e-05	0.0003369028006589786	HIPK2,CDKN2A,TP53,PML,ATM
819	Pancreatic adenocarcinoma	C0281361	4	320	5.26388533758e-05	0.00033731466227347615	STK11,CDKN2A,TP53,MDM2
820	Localized skin lesion	C0850826	5	530	5.26711752933e-05	0.00033772652388797364	STK11,CDKN2A,EP300,MDM2,ATM
821	Myeloid leukemia	C0023470	5	533	5.4345530433e-05	0.0003381383855024712	CDKN2A,TP53,PML,MDM2,ATM
822	Neurologic, endocrine, and pancreatic disease, multisystem, infantile-onset	C0030286	2	57	5.44343497823e-05	0.00033855024711696867	CDKN2A,TP53
823	Renal cell carcinoma, nonpapillary	C0007134	8	1418	5.49356702632e-05	0.0003389621087314662	PIN1,TP53INP1,STK11,CDKN2A,TP53,EP300,PML,MDM2
824	Oropharyngeal squamous cell carcinoma	C0280313	2	58	5.73530873278e-05	0.0003393739703459638	CDKN2A,TP53
853	Obstructive sleep apnea	C0520679	3	166	6.02194736398e-05	0.00035131795716639207	CDKN2A,EP300,MDM2
854	Neoplasm of the parathyroid gland	C0030521	2	59	6.03725324007e-05	0.0003517298187808896	TP53,MDM2
855	Cowden syndrome 1	C0018553	2	59	6.03725324007e-05	0.00035214168039538716	STK11,TP53
856	Adenocarcinoma, Endometrioid	C1569637	2	59	6.03725324007e-05	0.0003525535420098847	CDKN2A,TP53
857	cancer recurrence	C0920420	2	59	6.03725324007e-05	0.00035296540362438224	TP53,PML
858	Uterine leiomyoma	C0042133	4	331	6.17712542572e-05	0.00035337726523887973	CDKN2A,TP53,KAT6A,MDM2
859	Neoplasm Invasiveness	C0027626	3	168	6.3087627569e-05	0.0003537891268533773	NUAK1,CDKN2A,TP53
860	Lymphatic Metastasis	C0024232	3	168	6.3087627569e-05	0.0003542009884678748	CDKN2A,TP53,MDM2
861	CNS symptom	C1457887	2	60	6.34942442306e-05	0.0003546128500823723	CDKN2A,TP53
862	Head and Neck Neoplasms	C0018671	4	333	6.35555296755e-05	0.00035502471169686985	PIN1,CDKN2A,TP53,MDM2
863	Renal fibrosis	C0151650	3	169	6.45585106342e-05	0.00035543657331136734	HIPK2,TP53,ATM
864	Tumor necrosis	C0333516	3	170	6.60542919535e-05	0.00035584843492586493	CDKN2A,TP53,MDM2
865	Infiltrating Cervical Carcinoma	C1334177	2	61	6.67198645854e-05	0.0003562602965403625	CDKN2A,TP53
866	Malignant neoplasm of the central nervous system	C0348374	2	61	6.67198645854e-05	0.00035667215815485997	CDKN2A,TP53
867	Pancreatic intraepithelial neoplasia	C1301034	2	61	6.67198645854e-05	0.0003570840197693575	CDKN2A,TP53
868	Cachexia	C0006625	3	171	6.75752012856e-05	0.00035749588138385505	UBC,RPS27A,ATM
869	Ischemic Cerebrovascular Accident	C3272363	4	338	6.81908432241e-05	0.00035790774299835254	PIN1,CDKN2A,TP53,ATM
870	Non-Hodgkin lymphoma	C0024305	5	556	6.8652153386e-05	0.0003583196046128501	CDKN2A,TP53,PRMT5,MDM2,ATM
871	Turcot syndrome	C0265325	2	62	7.00508810783e-05	0.00035873146622734757	CDKN2A,TP53
872	Childhood Leukemia	C1332977	2	62	7.00508810783e-05	0.00035914332784184517	BRPF1,MDM2
873	Anaplastic carcinoma	C0205696	2	62	7.00508810783e-05	0.0003595551894563427	TP53,ATM
874	Chronic myeloid leukemia	C0023473	6	822	7.05751434417e-05	0.0003599670510708402	CDKN2A,TP53,EP300,PML,MDM2,ATM
899	Carcinoma breast stage IV	C0278488	4	342	7.20837140541e-05	0.0003702635914332784	STK11,CDKN2A,TP53,MDM2
900	Nevus	C0497388	3	174	7.22913283122e-05	0.00037067545304777594	CDKN2A,TP53,MDM2
901	Dissecting aneurysm of the thoracic aorta	C0729233	3	174	7.22913283122e-05	0.0003710873146622735	CDKN2A,TP53,ATM
902	Vitreoretinopathy, neovascular inflammatory, 193235 (3)	C0242852	2	63	7.34888761454e-05	0.000371499176276771	TP53,MDM2
903	Thymoma	C0040100	3	176	7.55658257844e-05	0.00037191103789126857	CDKN2A,TP53,ATM
904	Pancreatic Ductal Adenocarcinoma	C1335302	5	567	7.64852870803e-05	0.0003723228995057661	STK11,CDKN2A,TP53,MDM2,ATM
905	Breast Fibrocystic Disease	C0016034	2	64	7.70353853404e-05	0.0003727347611202636	TP53,MDM2
906	Early-Stage Breast Carcinoma	C2986665	2	64	7.70353853404e-05	0.00037314662273476115	TP53,ATM
907	Refractory cancer	C0677936	2	64	7.70353853404e-05	0.00037355848434925863	TP53,PML
908	Ovarian Serous Adenocarcinoma	C1335177	2	64	7.70353853404e-05	0.0003739703459637562	TP53,DYRK2
909	Rhabdoid tumors, somatic, 609322 (3)	C0206743	2	64	7.70353853404e-05	0.0003743822075782537	CDKN2A,TP53
910	Synovial sarcoma	C0039101	3	178	7.89471684502e-05	0.0003747940691927512	CDKN2A,TP53,MDM2
911	Angiogenic Switch	C1510885	2	65	8.06920569318e-05	0.0003752059308072488	CDKN2A,TP53
912	Extraosseous Ewings sarcoma-primitive neuroepithelial tumor	C0279980	2	65	8.06920569318e-05	0.0003756177924217463	CDKN2A,TP53
913	Gonadal neoplasm	C0239763	2	65	8.06920569318e-05	0.00037602965403624384	STK11,EP300
914	Atypical nevus	C0205748	2	65	8.06920569318e-05	0.0003764415156507414	CDKN2A,TP53
915	Primary hyperaldosteronism	C1384514	2	65	8.06920569318e-05	0.00037685337726523887	TP53,ATM
916	Embryonal Carcinoma	C0206659	3	181	8.42241944465e-05	0.0003772652388797364	CDKN2A,TP53,MDM2
917	Fibroadenoma of the breast	C0178421	2	66	8.44603653326e-05	0.0003776771004942339	CDKN2A,TP53
936	Laryngeal carcinoma	C0595989	3	184	8.97535768325e-05	0.000385502471169687	CDKN2A,TP53,MDM2
937	Esophageal carcinoma	C0152018	5	585	9.08328039765e-05	0.00038591433278418455	STK11,CDKN2A,TP53,MDM2,ATM
938	Abnormality of adrenal morphology	C4023213	2	68	9.23381364415e-05	0.00038632619439868203	TP53,MDM2
939	Histiocytosis, Langerhans-Cell	C0019621	2	68	9.23381364415e-05	0.0003867380560131796	CDKN2A,TP53
940	Hepatosplenic schistosomiasis	C0036323	2	68	9.23381364415e-05	0.0003871499176276771	CDKN2A,TP53
941	Chronic obstructive pulmonary disease	C0024117	6	865	9.71270869048e-05	0.0003875617792421746	PIN1,STK11,CDKN2A,TP53,MDM2,ATM
942	Adenocarcinoma of the large intestine	C1319315	3	189	9.95498126143e-05	0.00038797364085667215	CDKN2A,TP53,MDM2
943	Giant Cell Tumors	C0017525	2	70	0.000100680900825	0.0003883855024711697	TP53,MDM2
944	Well Differentiated Oligodendroglioma	C0751396	3	191	0.000103677911714	0.00038879736408566724	CDKN2A,TP53,MDM2
945	Dilated cardiomyopathy 1A	C1449563	3	191	0.000103677911714	0.0003892092257001648	CDKN2A,TP53,MDM2
946	Fibrosis	C0016059	3	191	0.000103677911714	0.00038962108731466227	TP53,MDM2,ATM
947	Secondary malignant neoplasm of pancreas	C3266877	8	1540	0.000103955613697	0.0003900329489291598	PIN1,STK11,CDKN2A,TP53,EP300,PML,MDM2,ATM
948	Retroviridae Infections	C0035369	2	71	0.000105030459156	0.0003904448105436573	STK11,TP53
949	Well Differentiated Pancreatic Endocrine Tumor	C1337011	2	71	0.000105030459156	0.00039085667215815485	CDKN2A,TP53
971	T-cell acute lymphoblastic leukemias	C1961099	4	371	0.000105698047263	0.00039991762767710047	STK11,CDKN2A,TP53,ATM
972	Polycythemia vera	C0032463	3	192	0.000105787942643	0.000400329489291598	CDKN2A,TP53,MDM2
973	Tuberous sclerosis syndrome	C0041341	3	192	0.000105787942643	0.00040074135090609555	STK11,CDKN2A,TP53
974	Early onset of sexual maturation	C4022392	2	72	0.000109500850889	0.0004011532125205931	STK11,EP300
975	Somatic mutation	C0544886	2	72	0.000109500850889	0.00040156507413509064	STK11,TP53
976	Abnormality of the gastrointestinal tract	C4023588	6	886	0.000112789470057	0.0004019769357495882	STK11,CDKN2A,TP53,EP300,MDM2,ATM
977	Hepatitis	C0019159	4	377	0.000113948959936	0.00040238879736408567	CDKN2A,TP53,PML,ATM
978	Esophageal Squamous Cell Carcinoma	C0279626	6	888	0.000114382831525	0.0004028006589785832	PIN1,CDKN2A,TP53,EP300,MDM2,ATM
979	Papilloma	C0030354	3	196	0.000114541436376	0.0004032125205930807	CDKN2A,TP53,MDM2
980	Granulomatosis with Polyangiitis	C3495801	2	74	0.000118810119494	0.00040362438220757825	TP53,MDM2
981	Neoplasm of the adrenal cortex	C0001618	2	74	0.000118810119494	0.0004040362438220758	TP53,MDM2
982	Breast Cancer Model	C1511291	2	74	0.000118810119494	0.00040444810543657333	PIN1,MDM2
983	Embryonal neoplasm	C0027654	2	74	0.000118810119494	0.0004048599670510709	STK11,TP53
984	Spots on skin	C0848332	3	198	0.000119110099481	0.00040527182866556836	CDKN2A,TP53,ATM
985	Rhabdomyosarcoma alveolar	C0035412	4	381	0.000119718866197	0.0004056836902800659	CDKN2A,TP53,MDM2,ATM
1010	Melanoma	C0025202	10	2386	0.000125212297043	0.0004159802306425041	ING2,TP53INP1,STK11,NUAK1,CDKN2A,TP53,EP300,PPP1R13B,MDM2,ATM
1011	B Acute Lymphoblastic Leukemia with t(9;22)(q34;q11.2); BCR-ABL1	C1292769	4	385	0.000125710912234	0.00041639209225700165	CDKN2A,TP53,MDM2,ATM
1012	Medullary thyroid carcinoma	C0238462	3	201	0.000126209172105	0.0004168039538714992	STK11,TP53,MDM2
1013	Undifferentiated leukemia	C1378511	2	76	0.00012862062661	0.00041721581548599673	TP53,PML
1014	Paragangliomas 1	C0030421	2	76	0.00012862062661	0.0004176276771004943	CDKN2A,TP53
1015	Adenovirus Infections	C0001486	2	76	0.00012862062661	0.00041803953871499176	TP53,MDM2
1016	Malignant Childhood Neoplasm	C0278704	2	76	0.00012862062661	0.0004184514003294893	CDKN2A,TP53
1017	Lymphoma, Follicular	C0024301	4	389	0.000131930828526	0.00041886326194398685	CDKN2A,TP53,EP300,MDM2
1018	Urothelial Carcinoma	C0007138	4	391	0.00013512810642	0.00041927512355848434	CDKN2A,TP53,EP300,MDM2
1019	Transient ischemic attack	C0007787	3	205	0.000136145993533	0.0004196869851729819	TP53,EP300,MDM2
1020	Intraocular melanoma	C0220633	3	206	0.000138716251264	0.00042009884678747937	CDKN2A,TP53,MDM2
1021	Stevens-Johnson Syndrome	C0038325	2	78	0.000138944361157	0.00042051070840197697	EP300,PML
1022	Salivary gland neoplasm	C0036095	2	78	0.000138944361157	0.0004209225700164745	TP53,MDM2
1023	Disorders of Intracellular Cobalamin Metabolism	C0025517	4	394	0.000140035246014	0.000421334431630972	STK11,CDKN2A,TP53,ATM
1024	Mammary Neoplasms, Experimental	C0024668	3	207	0.000141321585041	0.00042174629324546954	PIN1,CDKN2A,TP53
1025	Familial adenomatous polyposis 1	C0032580	4	395	0.000141701002375	0.00042215815485996703	HIPK2,CDKN2A,TP53,ATM
1026	Prostatic Neoplasms	C0033578	8	1606	0.00014324654635	0.0004225700164744646	PIN1,CDKN2A,TP53,EP300,PML,RPS27A,MDM2,ATM
1027	Neoplasm, Residual	C0242596	3	208	0.0001439621228	0.0004229818780889621	CDKN2A,TP53,PML
1028	Leukemia, Myeloid, Chronic-Phase	C0023474	2	79	0.00014430230216	0.0004233937397034596	CDKN2A,TP53
1052	Abnormality of female internal genitalia	C4025900	4	398	0.000146789629836	0.0004332784184514003	STK11,TP53,EP300,ATM
1053	Myelodysplastic syndrome	C3463824	4	399	0.000148516646379	0.0004336902800658979	HIPK2,CDKN2A,TP53,ATM
1054	Metaplasia	C0025568	2	80	0.000149792959822	0.0004341021416803954	CDKN2A,TP53
1055	Duodenal Ulcer	C0013295	2	80	0.000149792959822	0.00043451400329489294	ING2,TP53
1056	Azorean disease	C0024408	2	80	0.000149792959822	0.00043492586490939043	TP53,ATM
1057	Malignant neoplasm of kidney	C0740457	4	401	0.000152017319003	0.000435337726523888	PIN1,CDKN2A,TP53,MDM2
1058	Ischemic stroke	C0948008	4	401	0.000152017319003	0.0004357495881383855	PIN1,CDKN2A,TP53,ATM
1059	Chromosome Aberrations	C0008625	2	81	0.000155417813878	0.000436161449752883	TP53,ATM
1060	Multiple Endocrine Neoplasia Type 1	C0025267	2	81	0.000155417813878	0.00043657331136738055	CDKN2A,TP53
1061	Cafe-au-lait spot	C0221263	2	81	0.000155417813878	0.0004369851729818781	EP300,ATM
1062	Acute Undifferentiated Leukemia	C0280141	2	81	0.000155417813878	0.00043739703459637564	TP53,PML
1063	Pregnancy loss	C0156543	2	81	0.000155417813878	0.0004378088962108732	TP53,MDM2
1064	Cancer of the lower GI tract	C0006826	4	403	0.000155581033699	0.00043822075782537067	PIN1,STK11,TP53,ATM
1065	Malignant tumor of esophagus	C0546837	5	650	0.000161494069219	0.0004386326194398682	STK11,CDKN2A,TP53,MDM2,ATM
1066	granulosa cell tumor	C0018206	2	83	0.00016707588466	0.00043904448105436575	CDKN2A,TP53
1067	High-Grade Squamous Intraepithelial Lesions	C0333875	2	83	0.00016707588466	0.00043945634266886324	CDKN2A,TP53
1068	Chordoma	C0008487	2	83	0.00016707588466	0.0004398682042833608	CDKN2A,TP53
1069	Demyelinating Diseases	C0011303	2	83	0.00016707588466	0.00044028006589785833	TP53,PML
1070	Undifferentiated carcinoma	C0205698	2	83	0.00016707588466	0.00044069192751235587	CDKN2A,TP53
1084	Alveolar rhabdomyosarcoma	C0206655	2	84	0.000173111915894	0.0004464579901153213	CDKN2A,TP53
1085	Thyroid carcinoma	C0549473	5	659	0.000174004048445	0.0004468698517298188	HIPK2,CDKN2A,TP53,MDM2,ATM
1086	Restenosis	C0333186	3	220	0.000178508043732	0.00044728171334431634	TP53,MDM2,ATM
1087	Hepatoblastoma	C0206624	3	220	0.000178508043732	0.00044769357495881383	CDKN2A,TP53,MDM2
1088	Dental malocclusion	C0024636	2	85	0.000179287868688	0.0004481054365733114	EP300,UBB
1089	Neoplasm of the liver	C0023903	7	1290	0.000182384809139	0.0004485172981878089	STK11,CDKN2A,TP53,TP53BP2,PML,MDM2,ATM
1090	Chondrosarcoma	C0008479	3	222	0.00018479932357	0.0004489291598023064	CDKN2A,TP53,MDM2
1091	Pterygium	C0033999	2	86	0.000185605315767	0.00044934102141680395	CDKN2A,TP53
1092	Chronic active hepatitis	C0520463	2	86	0.000185605315767	0.0004497528830313015	TP53,MDM2
1093	Lip and Oral Cavity Carcinoma	C0220641	4	419	0.0001864507222	0.00045016474464579904	CDKN2A,TP53,MDM2,ATM
1094	Anaplastic thyroid carcinoma	C0238461	3	223	0.000188004354762	0.0004505766062602966	CDKN2A,TP53,ATM
1095	FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder)	C3469521	3	223	0.000188004354762	0.00045098846787479407	PIN1,TP53,ATM
1096	Cancer of mouth	C0153381	4	420	0.000188524682805	0.0004514003294892916	CDKN2A,TP53,MDM2,ATM
1097	Secondary hypertriglyceridemia	C0027627	12	3444	0.000189660747289	0.0004518121911037891	PIN1,HIPK2,STK11,NUAK1,CDKN2A,TP53,EP300,TP53BP2,PML,MDM2,DYRK2,ATM
1123	Embryonal rhabdomyosarcoma	C0206656	2	87	0.000192065467746	0.00046252059308072484	TP53,MDM2
1124	Liver regeneration disorder	C1318485	2	87	0.000192065467746	0.00046293245469522244	STK11,TP53
1125	Carcinoid tumor no ICD-O subtype	C0334299	2	87	0.000192065467746	0.00046334431630972	CDKN2A,TP53
1126	Herpes NOS	C0019340	2	87	0.000192065467746	0.00046375617792421747	CDKN2A,TP53
1127	Recurrent upper respiratory tract infections	C0581381	2	88	0.000198669947478	0.000464168039538715	EP300,ATM
1128	Tumor Promotion	C1519689	2	88	0.000198669947478	0.0004645799011532125	TP53,MDM2
1129	Abnormal internal genitalia	C4025824	4	426	0.000201341986988	0.00046499176276771004	STK11,TP53,EP300,ATM
1130	Plasmacytoma	C0032131	2	89	0.000205419976537	0.0004654036243822076	NUAK1,CDKN2A
1131	Adrenocortical adenoma	C0206667	2	89	0.000205419976537	0.0004658154859967051	TP53,ATM
1132	Morphological abnormality of the gastrointestinal tract	C4021073	5	682	0.000209493436376	0.0004662273476112027	STK11,CDKN2A,TP53,EP300,MDM2
1133	Abnormality of digestive system morphology	C4293691	5	682	0.000209493436376	0.00046663920922570016	STK11,CDKN2A,TP53,EP300,MDM2
1134	Acute promyelocytic leukemia	C0023487	4	431	0.000212523338421	0.0004670510708401977	PIN1,CDKN2A,TP53,PML
1135	Anaplasia	C0002793	3	231	0.000215109516707	0.00046746293245469525	CDKN2A,TP53,MDM2
1136	Invasive Ductal Breast Carcinoma	C1134719	3	231	0.000215109516707	0.00046787479406919274	TP53,MDM2,ATM
1137	Esophageal Neoplasms	C0014859	5	686	0.000216211572971	0.0004682866556836903	STK11,CDKN2A,TP53,MDM2,ATM
1153	Sporadic	C0205422	2	92	0.000226558167346	0.00047487644151565075	STK11,EP300
1154	Lymphoproliferative disorder	C0024314	3	236	0.000233418437057	0.00047528830313014824	TP53,MDM2,ATM
1155	Ovarian Diseases	C0029928	3	236	0.000233418437057	0.00047570016474464584	STK11,NOC2L,ATM
1156	Parathyroid adenoma	C0262587	2	93	0.000233904921448	0.0004761120263591434	CDKN2A,TP53
1157	Carcinoma, Squamous Cell	C0007097	2	93	0.000233904921448	0.00047652388797364087	ING5,TP53
1158	Merkel cell carcinoma	C0007129	2	94	0.000241404168647	0.0004769357495881384	CDKN2A,TP53
1159	Adenocarcinoma, Clear Cell	C0206681	2	94	0.000241404168647	0.0004773476112026359	TP53,MDM2
1160	Chronic ulcerative colitis	C2919828	2	94	0.000241404168647	0.00047775947281713345	CDKN2A,TP53
1172	Pleural Mesothelioma	C0812413	3	240	0.000248854412705	0.0004827018121911038	CDKN2A,TP53,MDM2
1173	Neurodegenerative Diseases	C0524851	5	706	0.000252407259174	0.00048311367380560134	PIN1,CDKN2A,TP53,UBB,ATM
1174	Abnormality of the female genitalia	C4023820	4	449	0.000256750756883	0.0004835255354200989	STK11,TP53,EP300,ATM
1175	Interstitial fibrosis	C3887486	2	97	0.000264831771573	0.0004839373970345964	CDKN2A,TP53
1189	Precancerous Conditions	C0032927	4	455	0.000272949931129	0.0004897034596375618	CDKN2A,TP53,MDM2,ATM
1190	Hepatitis C, Chronic	C0524910	4	455	0.000272949931129	0.0004901153212520593	CDKN2A,TP53,MDM2,ATM
1191	Teratocarcinoma	C0206664	2	99	0.00028123852418	0.0004905271828665568	CDKN2A,TP53
1192	Hemochromatosis	C0018995	2	99	0.00028123852418	0.0004909390444810544	TP53,MDM2
1193	Fanconi anemia	C0015625	3	249	0.000286256714635	0.0004913509060955519	PIN1,TP53,ATM
1194	Leukemia, B-Cell	C2004493	2	100	0.000289682524576	0.0004917627677100494	TP53,ATM
1195	Advanced cancer	C0877373	2	100	0.000289682524576	0.000492174629324547	TP53,MDM2
1196	Cystitis	C0010692	2	100	0.000289682524576	0.0004925864909390446	CDKN2A,TP53
1197	Neuroendocrine neoplasm	C0206754	3	252	0.000299575856557	0.000492998352553542	CDKN2A,TP53,ATM
1208	Respiratory distress	C0476273	2	102	0.000307058317811	0.0004975288303130149	EP300,KAT6A
1209	Fibrosarcoma	C0016057	3	254	0.000308699161951	0.0004979406919275123	CDKN2A,TP53,MDM2
1210	Adult T-Cell Lymphoma/Leukemia	C0023493	4	469	0.000313774654112	0.0004983525535420098	CDKN2A,TP53,MDM2,ATM
1211	Endometrial adenocarcinoma	C1153706	2	103	0.000315992885492	0.0004987644151565074	TP53,MDM2
1212	Testicular Germ Cell Tumor	C1336708	2	103	0.000315992885492	0.0004991762767710049	STK11,TP53
1213	Adenoma of large intestine	C1302401	3	257	0.000322756281759	0.0004995881383855025	STK11,CDKN2A,TP53
1214	Neuroectodermal neoplasm	C0206093	2	104	0.000325093631891	0.0005	CDKN2A,TP53
1215	Abnormal spermatogenesis	C0520933	2	104	0.000325093631891	0.0005004118616144976	ING2,ATM
1216	Retinoblastoma	C0035335	4	473	0.000326249434695	0.0005008237232289951	CDKN2A,TP53,PRMT5,MDM2
1230	NOONAN-LIKE/MULTIPLE GIANT CELL LESION SYNDROME (disorder)	C0221198	2	105	0.000334361934454	0.0005065897858319605	CDKN2A,TP53
1231	Rhabdoid Tumor of the Kidney	C0854917	2	105	0.000334361934454	0.0005070016474464581	STK11,TP53
1232	Neoplasm of the rectum	C0034885	2	105	0.000334361934454	0.0005074135090609555	STK11,TP53
1233	High grade serous carcinoma	C0206701	2	105	0.000334361934454	0.0005078253706754531	CDKN2A,TP53
1234	Acute megakaryocytic leukemia	C0023462	2	106	0.000343799051991	0.0005082372322899505	TP53,PML
1235	Frontotemporal dementia, ubiquitin-positive	C0236642	2	106	0.000343799051991	0.0005086490939044481	PIN1,UBB
1236	Pancreatic Neoplasms	C0030297	5	750	0.000348923800148	0.0005090609555189456	STK11,CDKN2A,TP53,MDM2,ATM
1237	Anaplastic large cell lymphoma, ALK negative	C0206180	3	263	0.000352241068217	0.0005094728171334432	TP53INP1,CDKN2A,TP53
1238	Precursor B-Cell Lymphoblastic Leukemia-Lymphoma	C0023485	2	107	0.000353406354494	0.0005098846787479407	CDKN2A,TP53
1239	Lung cancer	C0684249	9	2234	0.000355911554471	0.0005102965403624382	PIN1,STK11,CDKN2A,TP53,EP300,PRMT5,PML,MDM2,ATM
1240	Carcinoma, Small Cell	C0262584	2	108	0.000363185169916	0.0005107084019769358	CDKN2A,TP53
1254	Malignant mesothelioma	C0345967	3	266	0.00036768594418	0.0005164744645799012	CDKN2A,TP53,MDM2
1255	Primary sclerosing cholangitis	C0566602	2	109	0.000373136701314	0.0005168863261943987	CDKN2A,TP53
1256	Hairy Cell Leukemia	C0023443	2	110	0.000383262346871	0.0005172981878088963	CDKN2A,TP53
1257	Helicobacter Infections	C0079487	2	110	0.000383262346871	0.0005177100494233938	TP53,MDM2
1258	Carotid Atherosclerosis	C0577631	2	111	0.000393563370633	0.0005181219110378913	CDKN2A,TP53
1259	Neoplasm of the endocrine system	C0014132	2	111	0.000393563370633	0.0005185337726523887	TP53,MDM2
1260	Synovitis	C0039103	2	111	0.000393563370633	0.0005189456342668863	TP53,MDM2
1261	Retinal detachment	C0035305	2	111	0.000393563370633	0.0005193574958813838	TP53,MDM2
1265	Virus Diseases	C0042769	5	772	0.000406991036678	0.000521004942339374	CDKN2A,TP53,PML,MDM2,ATM
1266	Solid tumour	C0280100	5	772	0.000406991036678	0.0005214168039538715	CDKN2A,TP53,PML,MDM2,ATM
1267	Retrognathia	C0035353	2	114	0.000425531507353	0.0005218286655683691	EP300,KAT6A
1268	Multicystic renal dysplasia, bilateral	C1840451	2	114	0.000425531507353	0.0005222405271828665	TP53,PML
1269	early pregnancy	C0747845	2	114	0.000425531507353	0.0005226523887973641	TP53,MDM2
1270	Neoplasm Recurrence, Local	C0027643	3	277	0.000428487685573	0.0005230642504118617	CDKN2A,TP53,MDM2
1271	Pancreatitis	C0030305	3	277	0.000428487685573	0.0005234761120263592	CDKN2A,TP53,MDM2
1283	Cardiomegaly	C0018800	3	279	0.000440268951724	0.0005284184514003296	STK11,TP53,EP300
1284	Epithelioma	C0553707	3	280	0.000446245621894	0.0005288303130148269	HIPK2,CDKN2A,TP53
1285	Breast adenocarcinoma	C0858252	2	116	0.000447744009215	0.0005292421746293245	TP53,MDM2
1286	Intracranial Aneurysm	C0007766	2	116	0.000447744009215	0.0005296540362438221	CDKN2A,TP53
1287	Ovarian cyst	C0029927	2	116	0.000447744009215	0.0005300658978583196	STK11,ATM
1288	Mammary Ductal Carcinoma	C0021367	2	117	0.000459124157397	0.0005304777594728172	CDKN2A,TP53
1289	Peroxisome biogenesis disorder 1B	C0282527	1	25	0.000474416845637	0.0005308896210873146	ATM
1290	Primary malignant neoplasm of liver	C0024620	1	25	0.000474416845637	0.0005313014827018122	TP53
1291	Cutaneous lymphoma	C1276146	1	25	0.000474416845637	0.0005317133443163097	TP53
1292	Female hypogonadism	C0271578	1	25	0.000474416845637	0.0005321252059308073	ATM
1293	Abnormality of the radial head	C4021696	1	25	0.000474416845637	0.0005325370675453049	EP300
1294	Pleural Tuberculosis	C0041326	1	25	0.000474416845637	0.0005329489291598023	TP53
1295	Short clavicles	C0426799	1	25	0.000474416845637	0.0005333607907742999	PIN1
1296	Lobular carcinoma in situ of breast	C0279563	1	25	0.000474416845637	0.0005337726523887973	TP53
1297	Rubinstein-Taybi syndrome	C0035934	1	25	0.000474416845637	0.0005341845140032949	EP300
1298	Gastric Adenocarcinoma	C0278701	3	286	0.000483331022738	0.0005345963756177924	CDKN2A,TP53,PML
1299	Precocious puberty	C0034013	2	120	0.000494375401771	0.0005350082372322899	STK11,EP300
1300	Squamous cell carcinoma of tongue	C0349566	2	120	0.000494375401771	0.0005354200988467874	CDKN2A,TP53
1301	Symptomatic human immunodeficiency virus infection	C0019693	8	1900	0.000503374097884	0.000535831960461285	PIN1,HIPK2,ING2,CDKN2A,TP53,PML,MDM2,ATM
1302	Abnormality of digestive system physiology	C4293692	6	1132	0.000504172842542	0.0005362438220757826	STK11,TP53,EP300,KAT6A,MDM2,ATM
1303	Achalasia	C0014848	1	26	0.000513537328579	0.0005366556836902801	TP53
1304	Epidermal cyst	C0014511	1	26	0.000513537328579	0.0005370675453047777	TP53
1305	Hereditary hemorrhagic telangiectasia type 2	C0039445	1	26	0.000513537328579	0.0005374794069192751	ATM
1306	Hypoplasia of the thymus	C0685891	1	26	0.000513537328579	0.0005378912685337727	ATM
1307	Lymphoid hyperplasia	C0333997	1	26	0.000513537328579	0.0005383031301482702	TP53
1308	Neoplasms, Multiple Primary	C0027663	1	26	0.000513537328579	0.0005387149917627678	CDKN2A
1309	Sarcoma, Epithelioid	C0205944	1	26	0.000513537328579	0.0005391268533772654	TP53
1310	Peripheral T-Cell Lymphoma	C0079774	2	122	0.000518814221605	0.0005395387149917627	TP53,ATM
1311	Telangiectases in sun-exposed and nonexposed skin	C0039446	2	123	0.000531318761801	0.0005399505766062603	TP53,ATM
1312	Carcinoma, Endometrioid	C0206687	2	123	0.000531318761801	0.0005403624382207578	CDKN2A,TP53
1313	Animal Mammary Neoplasms	C0024667	9	2352	0.000537843784676	0.0005407742998352554	PIN1,HIPK2,STK11,CDKN2A,TP53,EP300,PML,MDM2,ATM
